-+ 0.00%
-+ 0.00%
-+ 0.00%

ANKTIVA® WITH BCG DEMONSTRATES 96% SURVIVAL FROM BLADDER CANCER AT THREE YEARS WITH MEDIAN SURVIVAL NOT YET REACHED IN BCG-UNRESPONSIVE HIGH-GRADE PAPILLARY-ONLY NON-MUSCLE INVASIVE BLADDER CANCER

路透·12/16/2025 14:00:56

登录查看新闻详情